top of page

RiVOLUTiON
at the DCK 2024 in Leipzig

 

From March 24th to 26th, RiVOLUTiON GmbH was represented at this year's German Surgeons' Congress in Leipzig. This year, we were represented twice: Our innovations AlpiTube, Cryo-S Painless and The Insides System were presented in the Future Corner of the congress. The company's entire product portfolio was available to view at the other exhibition stand. Thank you for the successful days and the lively exchange at the RiVOLUTiON exhibition stands.

DCK2.jpeg

RiVOLUTiON sustainability concept
 

Since autumn of this 2023, RiVOLUTiON has been the exclusive distribution partner for Surgical Innovations and Microline Surgical. Both companies are in tune with the times with their innovative product lines that combine disposable and reusable instruments, as hospitals are more than ever required to develop concepts to save costs, resources, and waste. RiVOLUTiON GmbH is now able to implement a comprehensive sustainability concept together with hospitals.

 

More information ...

LinkedIn2.jpg
LinkedIn3.jpg

Portfolio News: The Insides Company

RiVOLUTiON GmbH is the exclusive distribution partner of Inside Company for Germany and Austria. Through the Inside Company system, people with secondary diseases due to short bowel syndrome such as chronic fistulas can be helped. A niche product that saves those affected a lot of suffering, is easy to use and enormously improves the quality of life, including the chance of intestinal regeneration. A real innovation and therefore an ideal addition to our innovation range..

2023-12-11 at 13.48.40.jpg

Adipositas Surgery Live Workshop

At the end of November, a two-day live workshop on the topic of “Primary and revision procedures in bariatric surgery” took place as part of the RiVOLUTiON Academy under the leadership of CEO Thomas Geir. Over 30 bariatric surgeons from all over Germany were able to experience and exchange ideas about new innovations and techniques through keynote speeches and live interventions. A big thank you for the successful event goes to the course leaders and surgeons Dr. med. Dmitrij Dajchin (St. Martinus Hospital), Prof. Dr. med. Frank A. Granderath (Neuwerk Hospital), Dr. med. Matthias Schlensak (Neuwerk Hospital).

More about RiVOLUTiON stapling portfolio

Successful 1st hands-on course 
as part of the Mainz School of Minimally Invasive Thoracic Surgery

 

Last week the first 2-day hands-on workshop took place as part of the Mainz European School of Minimally Invasive Thoracic Surgery. The participants could experience the surgeons Prof. DR. Eric Rößner (Mainz), Dr. Carlos Galvez Munoz (Alicante ESP), PD. Dr. Davor Stamenovic, PD Dr. Christian Galata live in 3 live surgeries in uniportal VATS. A total of 10 thoracic surgeons from all over Germany were there and, in addition to the live surgery performing uniportal VATS techinque, they also experienced the Mainz European School of Minimally Invasive Thoracic Surgery live online with a total of 100 other colleagues. RiVOLUTiON CEO Thomas Geir is already looking forward to the next hands-on course. More information about the RiVOLUTiON Academy workshops at www.rivolution.de.

MainzSchoolHandson2.jpeg
WorkshopWien.jpeg

OBSiDiAN Workshop in Vienna 

This week another international OBSiDiAN® workshop took place in the Saint John of God hospital in Vienna. Under the direction of Prof. Dr. Friedrich Herbst and Priv.-Doz. Dr. Bernhard Dauser, 8 surgeons from Germany, Italy, Bulgaria and Austria were able to gain insight into the use of the platelet-rich biomatrix OBSiDiAN®. RiVOLUTiON CEO Thomas Geir supervised the workshop on site.

Hands on course
Mainz School of Minimally Invasive Thoracic Surgery

 

Rivolution GmbH organizes together with Prof. Dr. Eric Rössner a two-day workshop as part of the Mainz European School of Minimally Invasive Thoracic Surgery. The 2-day hands-on course starts with an impulse lecture, participation in the online lectures of the Mainz School and hands-on training on the second day with live surgery in the Mainz university hospital. As a guest surgeon, we welcome Dr. Carlos Gálvez, who will lead together with Prof. Dr. Rößner the workshop. Rivolution CEO Thomas Geir is looking forward to the new professional education format in thoracic surgery and exciting workshop days.

mainzschool_news.jpg

At the request of several clinics, Rivolution GmbH organized another visitation tour with Dr. Diego González Rivas. The internship tour took us to 3 German health centers over 4 days. Thoracic surgeons experienced "Uniportal-VATS"method developed by Dr. Rivas live in a total of 6 surgeries. With the minimally invasive method for interventions in the chest area, Dr. Rivas is considered a pioneer in thoracic surgery. Many thanks to Dr. Rivas for his time and energy for this training trip.

RiVOLUTiON
at the DCK 2023

Last week RiVOLUTiON was represented at the DCK 2023 in Munich. A big thank you for the successful symposium on the topic "Innovative strategies for protection against anastomoses" goes to the speakers and top speakers Prof. Dr. Kai Nowak, Prof. Dr. Hans and Dr. Felice Nappi, who inspired more than 100 surgeons with this exciting topic. We look forward to great conversations, contacts and further trials of the innovative AlpiTube concept in colorectal surgery.

More about the product

DCK5.jpeg

CRYO-S PAINLESS
Cryoanalgesia in thoracic surgery 

The new year brings a lot of news that we would now like to share. The innovative CRYO-S® Painless process from the established European manufacturer Metrum Cryoflex is new to the RiVOLUTiON range. Thoracic surgery is still one of the most painful procedures for patients, during and especially after the operation. This is exactly where the CRYO-S® Painless procedure comes in: The use of cryoanalgesia, the targeted temporary freezing of intercostal nerve tracts, revolutionizes pain management in thoracic surgery. Freedom from pain, shorter hospital stays, reduction of painkillers (opiates) have a positive effect and the ERAS concept can be implemented perfectly.

More about the product

cryo_web_edited.png
FrankfurterMeeting.jpg

 Satelliten LUNCH Symposium
Frankfurter Meeting 11. Nov 2022

 


In the symposium, Dr. med Barbara Jacobi (Head of Adipositaszentrum Saarbrücken) presented the PSTBS study with powered staplers from Fulbright company. Furthermore, advantages, opportunities and differences in the use of different stapling technologies were shown. Powered stapling, as an evolution of mechanical staplers, is already widespread in everyday surgery. Powered Stapling impresses with 90 % less effort and 100 % stability when released, including increased compression force. Nevertheless, many surgeons prefer the proven mechanical stapler based on experience and the best surgical results. Dr. Victor Diaconu from Romania, as a top expert in the field of bariatric surgery, spoke about surgical procedures using mechanical stapling technology. He is Head of Bariatric Surgery at Provita Hospital in Bukarest/Romania and performs approximately 1,000 bariatric surgeries per year.

 

More about Stapling Portfollio

Meet us at DCK 2023 from April 26th to 28th at the Munich Exhibition Center. Under the umbrella topic "Innovative strategies for protection against anastomoses", a symposium with the top speakers Prof. Dr. Kai Nowak, Prof. Dr. Hans Fuchs and Dr.  Felice Nappi. A cooperation between Stryker and RiVOLUTiON enables a top-class professional symposium and illuminates innovative new strategies for protecting complex anastomoses in surgery.
 

We look forward to your interest in the symposium and your subsequent visit to our booth F00.73 in the foyer.

 

More on the Product AlpiTube

The ORSY study at the RoMed Clinic in Rosenheim started in mid-September. During the initial training, RiVOLUTiON CEO Thomas Geir was able to demonstrate the application with OBSiDiAN® ASG® together with Prof. Dr. med Kai Nowak, Dr. medical Ralph Holzer and Dr. Jakob Häckl (far right in the picture) successfully. After the successful start, nothing stands in the way of the ORSY study starting at the Rosenheim Clinic with the first patients.

 

More about OBSiDiAN®

With September the team around Dr. Milan Ceranic from the Clinical Center Belgrade also starts with the first patients in the ORSY study. During training with RiVOLUTiON CEO Thomas Geir in Belgrade, the application with the platelet-rich biomatrix OBSiDiAN® was tried out successfully together with Dr. Ceranic and his team. We look forward to the start of the study in Belgrade and to the results of the regenerative application of OBSiDiAN®.

 

More about OBSiDiAN®
 

Orsy_Belgrad.jpg
Duomed.jpeg

Recap of the training, certification & initiation of the ORSY trial at Ziekenhuis Oost-Limburg (ZOL). The ORSY study, organized by RiVOLTiON GmbH and Duomed Group, offers the possibility of subjecting the project to an independent scientific review in order to confirm the sustainable healing success in rectum surgery through the use of the fully autologously obtained OBSiDiAN®ASG® BioMatrix in a randomized controlled trial. The start of the trial inclusions is expected in the upcoming weeks.

Special thanks to Prof. Dr. Kurt Van der Speeten, Prof. Dr. Joep Knol, Marga Bogaert and Thomas Geir for this great collaboration.

 

More about OBSiDiAN®
 

OBSiDiAN® starts in Granada/Spain
 

 The application of the bioactive OBSiDiAN®ASG® Matrix has now also started in the university hospital of Granada. Dr. Jorge Ramos Anfiel and his team performed the first interventions in colorectal surgery. RiVOLUTiON CEO Thomas Geir was supported on site by our local partner company MBA Surgical Empowerment and was now able to give the university the final approval for the official start of the ORSY study in Spain.

 

More about OBSiDiAN®
 

IMG-20220729-WA0000.jpg
IMG-20220712-WA0005.jpg

Live workshops organized by the RiVOLUTiON Academy are the ideal form of hands-on training for surgeons. That is why several surgeons from Germany and Austria met again in mid-July in the Kepler University Hospital in Linz, under the leadership of PRIM. UNIV.-DOZ. Dr. Andreas Shamiyeh to follow the application of the bioactive matrix OBSiDiAN ASG® live in colorectal surgery and to learn the correct application. The innovative staple line products from the extensive portfolio of RiVOLUTiON GmbH and HCP Austria were also used.

 

More about OBSiDiAN®
 

3. UMICS
Fulbright Course in Lisbon

 

Last week, 14 surgeons from Europe met in Lisbon for the 3rd UMICS Fulbright Course. For two days, lectures, a cadaver lab and live surgeries were all about Dr. Diego González Rivas developed method "Uniportal-VATS". The workshop days were accompanied professionally by Dr. Rivas and Prof. Javier Gallego Poveda from the Lusiadas Hospital/Lisbon. RiVOLUTiON GmbH also took part with CEO Thomas Geir and 6 surgeons from all over Germany. Thanks to Fulbright for supporting and organizing the great event.

 

More about Fulbright Stapling Portfolio
 

IMG-20220620-WA0018_edited.jpg
IMG-20220610-WA0003.jpg

 First clinical observations show the 100% filling of the fistula with OBSiDiAN® RFT® and promising results. For patients, this means a higher chance of a quick and complete healing of the fistula and closure of the fistula tract. Last week, the first three surgeries using the bioactive matrix OBSiDiAN® RFT® took place at the Groene Hart Hospital in the Netherlands. The complex fistula interventions were carried out on site by, Dr. Coen Baeten, Dr. Dashti Faraj and Dr. Jesse Fest with the professional support of the Dutch RiVOLUTiON sales partner Duomed. RiVOLUTiON CEO Thomas Geir was happy about the successful product launch of OBSiDiAN® RFT® for the treatment of perinatal fistulas in Gouda.

 

More about OBSiDiAN®
 

 News from the RiVOLTiON Academy: Together with our Austrian sales partner HCP Austria, two OBSiDiAN® RFT® Live Workshop days took place last week. On the 1st day of the workshop, participants from Austria and Poland were on site and on the 2nd day of the workshop, participants from Austria, England, Ireland and the Emirates came to the Kepler University Hospital in Linz to look over OA Dr. Günther Klimbacher's shoulder, first theoretically and then in several live surgeries using the bioactive matrix OBSiDiAN® RFT® for complex perianal fistulas. A big "Thank you!" to Dr. Klimbacher for implementing the successful workshop.

 

More about OBSiDiAN
 

Linkedin_WS_Linz.jpg
Linkedin_Spain_Studienstart.jpg


ORSY initiation meeting
in Spain

The initiation meeting for the start of the ORSY study took place in Granada, Spain, at the beginning of May. With the support of MBA, our medical technology partner on site as well our CRO, our monitoring company Raffeiner. The course was laid for a successful start of the ORSY study in Spain.  

 

More about OBSiDiAN ®

 Even if Corona makes it difficult to always adhere to exact schedules, we are on course with the ORSY study. After the Kepler University Clinic Linz under the direction of Prim. Priv.-Doz. Dr. Andreas Shamiyeh and the St. John of God hospital in Graz under the direction of Prim. Prof. Dr. Felix Aigner and OA Dr. Gerald Seitinger has now also received the St. John of God hospital Vienna the green light from the ethics committee. The study will be conducted on site by Prof. Dr. Friedrich Herbst and Priv.-Doz. Dr. Bernhard Dauser and the first patients have already been introduced to the study..

 

More about OBSiDiAN
 

orsy.jpg
Orsay_Studie_Obsidianweb2_edited.jpg

Green light for the start of the RCT ORSY (OBSiDiAN in Rectal Surgery) study. The study offers the possibility to subject the project to an independent scientific assessment in order to confirm the sustainable healing success through the use of the completely autologously obtained OBSiDiAN ASG® BioMatrix in a randomized controlled study. 15 surgical departments from 7 European countries will take part. Last week the ethics committee and the CRO gave the green light for the start of studies in the Kepler University Clinic Linz under the direction of Prim. Priv.-Doz. Dr. Andreas Shamiyeh. This means that the first patients can be included in the clinical study.

After 3 years of intensive work, we are proud to be able to present the first published study on the use of OBSiDiAN ASG®. Under the direction of Prim. Priv.-Doz. Dr. Andreas Shamiyeh (Kepler University Hospital Linz) and Prof. Dr. Friedrich Herbst and Priv.-Doz. Dr. Bernhard Dauser (Johannes Gott Hospital Vienna), the promising results have now been published for the first time in the renowned Surgical Technology International Journal. The study shows a significant reduction in anastomotic leakage through the use of the autologously obtained OBSiDiAN ASG® BioMatrix.

The article is listed on PubMed, where RiVOLUTiON GmbH sponsored Open Access to support the dissemination of the study results to our partners and interested specialists in our work.

.

Download article

iStock-914789708.jpg
IMG-20211109-WA0008.jpg

Another successful workshop as part of the RiVOLUTiON Academy took place in mid-November at the Kepler University Hospital Linz. Under the direction of PRIM. UNIV.-DOZ. Dr. Andreas Shamiyeh 10 surgeons from all over the world met to learn more about the use and possibilities of OBSiDiAN ASG® in colorectal surgery during hands-on training. During the workshop, OA Dr. Günther Klimbacher developed the OBSiDiAN RFT® concept  in the treatment of complex, perianal fistulas and demonstrate via live surgery.

Rivolution GmbH is happy to have a new international partner in the OBSiDiAN® community. With Assut Europe, a top-class professional medical technology company comes on board to take regenerative medicine a step further in Italy with OBSiDiAN®. During the joint training with CEO Thomas Geir in Rome last week, the product specialists from Assut Europe were able to familiarize themselves with the use of OBSiDiAN® in colorectal surgery and learn a lot about its enormous potential.

To Assut Europe

assut.jpg
Verpackung_2_neu_edited.jpg

The intensive work of recent years has paid off: RiVOLUTiON GmbH, together with the manufacturer Vivostat, has been awarded the contract for a Europe-wide study for OBSiDiAN. An important step that can now be made by the European economic development program "Horizon 2020 - Research and Information Framework Program" for the implementation of a Europe-wide study. 15 surgical departments from 7 European countries (AT DE, CH, IT, ESP, B, DK) as well as a center from Serbia will take part.  

More information about the product

April 2021, OÖN

Regenerative medicine is also used in the Upper Austrian hospital of the Barmherzigen Schwerstern in Ried. Prim. Dr. Bernhard Furtmüller relies on the new process technology for intestinal operations, which aims at faster regeneration after the interventions with fewer risk factors. OBSiDiAN is being introduced in Ried as part of an Austria-wide study.  

Link to the report in the OÖN

Artikel Ried neu3_edited_edited.jpg
IMG-20210216-WA0001.jpg

the  RiVOLUTION GmbH, together with HCP Austria based in Salzburg, bundles the synergies in order to offer customers and partners even better solutions in surgery in the future. “Our companies complement each other across the board in their endeavor to introduce innovative products and sustainable processes in medical technology. Customers and patients benefit from this cooperation, '' says RiVOLUTION Managing Director Thomas Geir, who is happy to share this with him
HCP managing director Ulrich Pichler.

Link to broadcast

RiVOLUTiON managing director Thomas Geir came back from Dubai with a new partnership. The new partners AL Rowais Medical Dubai were convinced after the training with OBSiDiAN and are happy to be able to use the technology in hospitals in the future.

Link to more pictures

dubai_edited.jpg
alsfelder_edited.jpg

One of the most common risks in bowel surgery is that the staple suture does not last long after the operation and an anastomosis occurs. A solution and thus a completely new method can be found in a joint brainstorming session between Dr. med. Steffen Lancee and RiVOLUTiON emerged.  

Link to the article

bottom of page